BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,397,000 | -47.6% | 5,250,000 | -44.4% | 0.28% | -46.0% |
| Q4 2017 | $10,296,000 | -2.6% | 9,450,000 | 0.0% | 0.53% | -10.7% |
| Q3 2017 | $10,569,000 | +34.1% | 9,450,000 | +33.1% | 0.59% | +30.0% |
| Q2 2017 | $7,879,000 | +15.9% | 7,100,000 | +18.3% | 0.45% | +14.7% |
| Q1 2017 | $6,801,000 | -13.7% | 6,000,000 | -14.3% | 0.40% | -17.5% |
| Q4 2016 | $7,884,000 | -6.8% | 7,000,000 | 0.0% | 0.48% | -7.4% |
| Q3 2016 | $8,462,000 | +1.7% | 7,000,000 | -6.7% | 0.52% | -2.1% |
| Q2 2016 | $8,322,000 | -4.1% | 7,500,000 | 0.0% | 0.53% | -15.8% |
| Q1 2016 | $8,681,000 | +463.3% | 7,500,000 | +650.0% | 0.63% | +397.6% |
| Q2 2015 | $1,541,000 | -65.2% | 1,000,000 | -66.7% | 0.13% | -64.9% |
| Q1 2015 | $4,427,000 | – | 3,000,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MACKAY SHIELDS LLC | 37,179,000 | $41,455,000 | 2.06% |
| LINDEN ADVISORS LP | 24,592,000 | $27,360,000 | 1.20% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,025,000 | $13,415,000 | 1.15% |
| Ferox Capital Management LP | 3,465,000 | $3,889,000 | 1.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 44,823,000 | $49,860,000 | 0.90% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 40,514,000 | $45,097,000 | 0.70% |
| RWC Asset Management LLP | 7,500,000 | $8,322,000 | 0.53% |
| CSS LLC/IL | 4,196,000 | $4,653,000 | 0.31% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $2,231,000 | 0.24% |
| EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 3,750,000 | $4,176,000 | 0.19% |